Articles On Volpara Health Technologies (ASX:VHT)

ASX health sector down 0.94% for past week, while broader market falls 1.22% Under pressure CSL moves to reassure investors at US Capital Markets Day this week Imricor soars after world’s first VT ablation performed entirely under real-tim...

Mach7 Technologies (ASX:M7T) shareholders, customers and staff should know what to expect from new CEO Teri Thomas, who is adopting a similar playbook to the one to which everyone sang along at breast imaging house Volpara Health Technologi...

MoneyTalks is Stockhead’s drill down into what stocks investors are looking at right now. We tap our list of experts to hear what’s hot, their top picks and what they’re looking out for. In this edition we hear from senior healthcare analys...

Chemist giant Sigma is posting double-digit sales growth … … whilst rival EBOS meets guidance Mach 7 puts customers first in ‘back to basics’ approach   A little over six months after merging with Chemist Warehouse (CW), Sigma Healthcare...

Certain ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety and efficiency in healthcare For example, Imricor is pioneering cardiac ablations using MRI instead of traditional x-ray fluoroscopy t...

The winds of CEO change bloweth through the early commercial-stage end of the market Trial news from Neurizon and Blinklab Opthea’s latest setback brings perversely good news   The long-standing CEOs of two early commercial stage biotech...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Lunit INSIGHT MMG integrated into the clinical workflow of Australia’s BreastScre...

ASX small-cap shares can deliver wonderful returns for investors who are brave enough to look at them. In fact, in 2024, I'd rather buy smaller businesses than ASX blue-chip shares. Don't get me wrong, I think the ASX has many quality, lar...

Investing in ASX stocks makes a lot of sense for building wealth and perhaps creating a stream of passive income. That said, certain investments may work better for some investors than others, depending on their age bracket. I'm going to o...

There are great ASX growth shares for investors to choose from on the stock market. Some names with international potential are particularly compelling because of how much stronger that makes their potential growth. In this article, I'm go...

ASX health stocks flat in past five days in line with broader markets  Avita lowers full year 2023 guidance after slower progress in its customer’s VAC processes EBOS decides against acquisition of animal care business, reportedly Greencro...

I think it's a great time to invest in quality cheap ASX shares while we're being offered such good prices by the market. The only time when share prices become particularly attractive is when there's something to be genuinely concerned ab...

ASX health stocks rise in past five days and outpace broader markets for second week All study visits complete in Neuren’s Phase 2 clinical trial of NNZ-2591 in Phelan-McDermid Syndrome Ramsay Health Care after revealing that it has reach...

This could be a great time to invest in ASX growth shares during November whilst markets are uncertain and there’s a lot of volatility around. A fall of a share price doesn’t mean it’s not a good investment. In-fact, a cheaper price can be...

I like seeing the ASX share market go up and down because it gives us a better chance of investing at a price that can create good outperformance. Share prices regularly move quite substantially over the months – we can find stocks that may...

ASX health sector falls in line with broader markets on macroeconomic factors and global geopolitical tensions Health imaging stock Volpara announces fourth consecutive quarter of operating cashflow Several ASX healthcare names with positi...

The Volpara Health Technologies Ltd (ASX: VHT) share price is taking off on Tuesday. In afternoon trade, the health technology company's shares are up 13% to 72.5 cents. Why is the Volpara share price rocketing? Investors have been buying...

The Volpara Health Technologies Ltd (ASX: VHT) share price has jumped 6% after its latest FY24 update. The ASX healthcare share provides software for breast cancer screening imaging, analysis, and healthcare professional workflow. FY24 seco...

Broader market up in past five days but ASX sinks, now down  CSL caught up in sell down of global kidney dialysis related stocks   IMEXHS wins a $2 million contract with Colombia’s National Police Force Healthcare and life sciences expert...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

ASX wealth can help us aim to build a $50,000 portfolio into a much larger portfolio worth $100,000, $250,000, or even $500,000. It's certainly possible although I wouldn't recommend investors go for the riskiest, most speculative business...

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

In this article, I'm going to talk about two ASX growth shares that seem better value to me than NVIDIA Corp (NASDAQ: NVDA) shares. Nvidia has gone on an incredible run, up more than 210% this year and around 300% from mid-October. There...

ASX growth shares that have good operating profit margins and are delivering strong revenue growth can lead to good shareholder returns over time. Businesses that are smaller and earlier on in their growth journey can be very compelling in...

Reporting season is almost over, so this looks like it could be a good time to reflect on how companies performed and which ASX growth shares could kick on. Plenty of ASX shares have gone up over the last several months, but there are a few...

Medical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI aims to grab market share Stockhead reached out to Curvebeam AI CEO, Greg Brown   Despite the recent rally, the ASX Healthcare Index (XHJ) is...

The AUD has sunk to levels not seen since November last year We ask Datt Capital CEO, Emanuel Datt, what this would mean for stock investors And which ASX sectors and stocks would benefit the most   The recent turmoil in China has sent th...

I really like a number of ASX growth shares which seem as though they can deliver a lot of growth in the long-term because of the compounding effects year after year. Over the next few years I reckon both of the below companies could achiev...

ASX health stocks up 1% in the past five days in line with broader markets Volpara records third quarter of positive cashflow following successful growth strategy Gut health a popular theme at 17th Bioshares Biotech Summit along with immun...

Whilst the prevalence of Artificial intelligence has boosted the US-tech sector, with the likes of Nvidia and C3.ai seeing their share prices increase by 219% and 265% respectively since the start of the year, Down Under, tech stock valuati...

ASX growth shares can deliver much stronger returns for investors if we buy at the right price. A business that is growing its revenue/profit at over 10% per annum has a much better chance of delivering market-beating returns, in my view....

ASX small-cap shares usually seem to me like much better long-term picks for wealth-building than ASX blue-chip shares. The term blue chip describes the largest, most well-known and most financially secure businesses. In Australia, we’re...

The Volpara Health Technologies Ltd (ASX: VHT) share price is down 4% after reporting its FY24 first quarter, which was strong. Volpara FY24 first quarter The ASX healthcare share reported cash receipts of NZ$11 million, which was up 27% (o...

Share prices are constantly moving around. In my opinion, this can mean that opportunities can be found every day. With that in mind, I’m going to write about a few things that indicate to me an ASX stock is worth investing in. A change...

Global X said generative artificial intelligence has been the paradigm shift exciting investors in 2023 AI has become an integral part of some ASX companies across various sectors from healthcare to security Vection Technologies  has rele...

Artificial intelligence (AI) is disrupting a number of different services and industries. Some ASX shares are finding opportunities to boost the profit margin by using AI. Companies that are able to grow the revenue and profit margin can g...

ASX health stocks fall in  past five days with Power noting larger names trading on attractive valuations  Neuren Pharmaceuticals has expanded its current licensing agreement with Acadia Pharmaceuticals Pharmaxis reports positive results f...

There are always opportunities to be found on the ASX share market. Some might get a lot of attention, such as when large ASX mining shares go through a cyclical dip like BHP Group Ltd (ASX: BHP) did in late October 2022. There are probabl...

ASX growth shares can make really big returns if things go well. Companies that are growing revenue and seeing rising margins can accelerate returns for investors. I’d prefer to invest in companies that seem to have many years of growth pot...

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

If you decide to snaffle any of these cheap ASX shares, you may not even have to give up your morning coffee. Our Motley Fool writers have come up with their favoured stocks trading for under $3 for investors looking to add to their portfo...

ASX growth shares that can significantly grow their earnings from now into the future could be big investment opportunities. I love the look of a business that’s growing quickly and re-investing for more success. If they have a large add...

As we head into Tuesday afternoon trading, the Volpara Health Technologies Ltd (ASX: VHT) share price is running to the upside. Buoyed by a business update released this morning, the healthcare technology company’s shares are tracking 7%...

The Volpara Health Technologies Ltd (ASX: VHT) share price has gone up after the ASX healthcare share revealed a solid business update. Volpara’s software is used to “better understand cancer risk, empower patients in personal care decision...

We’re about to tick over into the next financial year. This could be a useful time to assess which ASX growth shares might be able to make good returns over the next 12 months and the longer-term. I’ve got my eyes on potential investments t...

The ASX growth shares I’m going to tell you about in this article are down significantly from their former highs. But, with their revenue growing exceptionally strongly, I’m optimistic about their outlook to deliver market-beating retu...

I think that ASX shares are the best way to deliver long-term capital growth for investors. To me, taking on a lot of debt is not an ideal way of growing wealth. It comes with a wipeout risk if the investor is unable to keep making the loa...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

The excitement surrounding artificial intelligence (AI) shares, both on the ASX and abroad, has been palpable these past few months. Who could be blamed for their interest when some companies in this fashionable industry showcase year-to-...

 Achieving cashflow positive is a major catalyst for tech companies, opening doors to greater growth opportunities Pick of tech baron Alex Waislitz, Jayride was cashflow positive in Q3 FY23 and forecasts an even stronger Q4  Volpara Health...